Weight-loss Drug Battle: Who Are the Latest Players Involved

Seeking Alpha13:30 ET

Morgan Stanley Assumes Rhythm Pharmaceuticals at Overweight, Maintains Price Target of $72

BenzingaMar 7 12:43 ET · Ratings

Morgan Stanley Initiates Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Announces Target Price $72

Moomoo NewsMar 7 07:31 ET · Ratings

Promising Market Potential for Rhythm Pharmaceuticals' Setmelanotide in Treating Hypothalamic Obesity

TipRanksMar 6 00:25 ET

Stifel Initiates Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Announces Target Price $78

Moomoo NewsMar 5 07:33 ET · Ratings

Express News | Rhythm Pharmaceuticals Inc : Stifel Resumes Coverage With Buy Rating; Price Target $78

ReutersMar 5 06:49 ET